LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 16 2025
0mins
Source: PRnewswire
Investigation Announcement: The Schall Law Firm is investigating Larimar Therapeutics, Inc. for potential violations of securities laws related to misleading statements and undisclosed information affecting investors.
Study Results and Stock Impact: Following the announcement of "positive" data from a study on Nomlabofusp, it was revealed that several participants experienced severe allergic reactions, leading to a significant drop of over 33.6% in Larimar's stock price.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like undefined with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
